Scientists at Mayo Clinic Develop Innovative Gene Therapy Delivery System Using Milk Cholangiocarcinoma, a rare and aggressive form of bile duct cancer, has long posed...

Scientists at Mayo Clinic Develop Innovative Gene Therapy Delivery System Using Milk Cholangiocarcinoma, a rare and aggressive form of bile duct cancer, has long posed a challenge for oncologists due to its late diagnosis and resistance to conventional therapies. Researchers at the Mayo Clinic have now unveiled a groundbreaking approach: using milk-derived nanoparticles to deliver gene-editing tools directly to cancer cells. By leveraging the natural structure of milk proteins, the team has engineered a system that can bypass the body’s defenses, a critical hurdle in cancer treatment. This method, still in early-stage trials, could redefine how gene therapy is administered for hard-to-treat malignancies. The breakthrough hinges on modifying milk proteins to act as carriers for CRISPR-based gene-editing...

Scientists at Mayo Clinic Develop Innovative Gene Therapy Delivery System Using Milk Cholangiocarcinoma, a rare and aggressive form of bile duct cancer, has long posed a challenge for oncologists due to its late diagnosis and resistance to conventional therapies. Researchers at the Mayo Clinic have now unveiled a groundbreaking approach: using milk-derived nanoparticles to deliver gene-editing tools directly to cancer cells. By leveraging the natural structure of milk proteins, the team has engineered a system that can bypass the body’s defenses, a critical hurdle in cancer treatment. This method, still in early-stage trials, could redefine how gene therapy is administered for hard-to-treat malignancies. The breakthrough hinges on modifying milk proteins to act as carriers for CRISPR-based gene-editing...